Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
New CRISPR-Based Therapies Initiated by 2024 End Using OpenCRISPR-1  | Categorical | 5 | 8 months ago | ||
Major Pharma Adoption of OpenCRISPR-1 by 2024 End? | Binary | 5 | 8 months ago | ||
Region with highest OpenCRISPR adoption by 2027  | Categorical | 5 | 8 months ago | ||
Ethical controversy over OpenCRISPR by 2025? | Binary | 5 | 8 months ago | ||
ProfluentBio files patent for OpenCRISPR by end of 2024? | Binary | 5 | 8 months ago | ||
First sector to adopt OpenCRISPR by 2026 | Categorical | 5 | 8 months ago | ||
Dominant application of OpenCRISPR by end of 2026 | Categorical | 5 | 8 months ago | ||
OpenCRISPR widespread in academia by 2025? | Binary | 5 | 8 months ago | ||
Patent Lawsuit Against ProfluentBio Over OpenCRISPR-1 by 2024 End? | Binary | 4 | 8 months ago | ||
First Sector to Report Breakthrough Using OpenCRISPR-1 | Categorical | 4 | 8 months ago | ||
Ethical Controversy over OpenCRISPR-1 by Mid-2025? | Binary | 4 | 8 months ago | ||
Academic Adoption Level of OpenCRISPR-1 by 2025 | Categorical | 3 | 8 months ago |